Actively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer

dc.contributor.authorBareke, H.
dc.contributor.authorFuentes, M.
dc.contributor.authorOladipo, A. A.
dc.contributor.authorOzbas, S.
dc.contributor.authorSalva, E.
dc.date.accessioned2026-02-06T18:28:45Z
dc.date.issued2021
dc.departmentDoğu Akdeniz Üniversitesi
dc.descriptionEuropean-Society-of-Gene-and-Cell-Therapy Collaborative Virtual Congress (ESGCT) -- OCT 19-22, 2021 -- ELECTR NETWORK
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipInonu University, Department of Scientific Research Projects [TOA-2019-1543]
dc.description.sponsorshipThe research was funded by Inonu University, Department of Scientific Research Projects (TOA-2019-1543).
dc.description.sponsorshipEuropean Soc Gene & Cell Therapy
dc.identifier.endpageA36
dc.identifier.issn1043-0342
dc.identifier.issn1557-7422
dc.identifier.issue19-20
dc.identifier.scopusqualityQ2
dc.identifier.startpageA36
dc.identifier.urihttps://hdl.handle.net/11129/11078
dc.identifier.volume32
dc.identifier.wosWOS:001023133000100
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherMary Ann Liebert, Inc
dc.relation.ispartofHuman Gene Therapy
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.titleActively targeted chitosan-based vector for efficient CRISPR-Cas9 mediated Tenascin-C gene editing in triple negative breast cancer
dc.typeConference Object

Files